Vapers Digest 19th July

Wednesday’s News at a glance:

Taxes on tobacco alternatives undermine harm reduction efforts

Guy Bentley, Reason Foundation

The government, at state and federal levels, imposes excise taxes on combustible cigarettes. Principally, the taxes serve to offset the costs smokers impose on non-smokers through increased healthcare demands, deter use (especially among minors), and raise revenue.

Since the Food and Drug Administration (FDA) was tasked with regulating tobacco products in 2009, a host of safer nicotine alternatives to cigarettes have entered the market, including e-cigarettes, modern oral nicotine, and heated tobacco. The FDA has authorized these products as part of a harm reduction strategy so that smokers who are unwilling or unable to quit cigarettes through traditional methods can switch to safer forms of nicotine.



Two From Dave Cross, Planet Of The Vapes

House of Lords

Vaping and tobacco harm reduction have been discussed in the House of Lords. Liberal Democrat Lord Storey raised the subject of prosecutions, pressed the Government on the subject of young people vaping, and asked the current administration to look at the banning of all flavoured vape products.

IBVTA responds to calls for ban on single use vapes

The Independent British Vape Trade Association (IBVTA) has responded to the Local Government Association (LGA) calling for the Government to ban the sale and manufacture of single use vapes by 2024. IBVTA’s members do not hold links to any company in the tobacco industry. The LGA represents councils in England and Wales.


NNA_Banner_Support_Trans



Experts fight back over Labor’s vaping crackdown

Australia News

FDA Is Funding and Approving Cigarettes

Mazen Saleh

With how news moves these days, it is easy to miss the drama unfolding in the tobacco world. Over the course of this year, the Food and Drug Administration announced a plan to reduce the nicotine in all cigarettes, outright ban all menthol cigarettes, and denied an application by JUUL to sell its products, only to turn around and suspend that ban as the company appealed the decision. All of this is eclipsed, however, by the fact that U.S. health agencies funded research trials for two very low nicotine (VLN) cigarette products — one of which is a menthol — that went on to receive approvals by the FDA as reduced-risk products.


Visit Nicotine Science & Policy for more News from around the World

NSP-DG


innco-02

Tagged with: , , , , , , , , , , , , , , ,